MedTrace Logo

Interest of Two Digital Devices for the Diagnosis of Neurocognitive Disorders in Elderly People With Cognitive Symptoms.

NCT06032611 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-09-13

No results posted yet for this study

Summary

The goal of this clinical trial is to compare conventional clinical data collected as part of usual practice with data collected by the two digital tools to help diagnose major and minor neurocognitive disorders in elderly people consulting a memory center for cognitive complaints. The main question\[s\] it aims to answer are:

* Is it possible to create a classification between the different intensities of cognitive impairment?
* Is it possible to create a diagnostic tool consistent with the reference diagnosis? Participants will be asked to complete a series of cognitive and fine motor tasks, and will be given questionnaires on their lifestyle and medical history. They will be asked to wear a connected watch for 1 week.

There is no comparison group.

Conditions

  • Age-related Cognitive Decline
  • Computers, Handheld
  • Neurocognitive Disorders

Interventions

DIAGNOSTIC_TEST

COGNUM_ALZVR

Participants will complete a battery of tests/quizzes: * cognitive tests * medical questionnaire * lifestyle/fragility questionnaire * digital clock test * fine motor skills tests They will also wear a connected watch for 7 days.

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Université d'Évry

    collaborator OTHER

  • Hôpital Charles Foix

    collaborator OTHER

  • RIVAGES

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-17
Primary Completion
2024-04-17
Completion
2024-04-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06032611 on ClinicalTrials.gov